U.S. Physical Therapy, Inc. (USPH) Rating Lowered to Sell at Zacks Investment Research

U.S. Physical Therapy, Inc. (NYSE:USPH) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

A number of other research analysts have also recently issued reports on the company. BidaskClub upgraded U.S. Physical Therapy from a “strong sell” rating to a “sell” rating in a research note on Thursday, September 28th. Cantor Fitzgerald reiterated a “buy” rating and set a $72.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, September 26th. Sidoti upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $62.00 to $74.00 in a research note on Friday, September 8th. Jefferies Group LLC set a $65.00 price target on U.S. Physical Therapy and gave the stock a “hold” rating in a research note on Friday, August 4th. Finally, Barrington Research upgraded U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $68.00 price target for the company in a research note on Monday, July 3rd. Two analysts have rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company’s stock. U.S. Physical Therapy currently has a consensus rating of “Hold” and an average target price of $68.60.

Shares of U.S. Physical Therapy (NYSE:USPH) opened at 63.50 on Friday. U.S. Physical Therapy has a one year low of $51.96 and a one year high of $78.00. The company has a market cap of $798.89 million, a P/E ratio of 40.19 and a beta of 1.06. The company’s 50-day moving average price is $59.80 and its 200 day moving average price is $62.56.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $0.59 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.60 by ($0.01). The company had revenue of $104.25 million for the quarter, compared to analysts’ expectations of $102.93 million. U.S. Physical Therapy had a net margin of 5.65% and a return on equity of 12.91%. On average, equities research analysts anticipate that U.S. Physical Therapy will post $2.12 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “U.S. Physical Therapy, Inc. (USPH) Rating Lowered to Sell at Zacks Investment Research” was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://ledgergazette.com/2017/10/09/u-s-physical-therapy-inc-usph-rating-lowered-to-sell-at-zacks-investment-research.html.

In related news, CFO Lawrance W. Mcafee sold 3,000 shares of U.S. Physical Therapy stock in a transaction on Friday, August 11th. The stock was sold at an average price of $62.04, for a total value of $186,120.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Glenn Mcdowell sold 2,598 shares of U.S. Physical Therapy stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $57.00, for a total value of $148,086.00. The disclosure for this sale can be found here. Insiders sold 13,266 shares of company stock valued at $801,134 in the last 90 days. Company insiders own 3.10% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the stock. Invictus RG bought a new stake in shares of U.S. Physical Therapy in the first quarter worth $100,000. Pinebridge Investments L.P. grew its holdings in shares of U.S. Physical Therapy by 1.0% in the second quarter. Pinebridge Investments L.P. now owns 1,650 shares of the company’s stock worth $100,000 after acquiring an additional 17 shares during the period. Sei Investments Co. grew its holdings in shares of U.S. Physical Therapy by 9.0% in the first quarter. Sei Investments Co. now owns 1,954 shares of the company’s stock worth $128,000 after acquiring an additional 162 shares during the period. State of Alaska Department of Revenue grew its holdings in shares of U.S. Physical Therapy by 77.8% in the second quarter. State of Alaska Department of Revenue now owns 2,454 shares of the company’s stock worth $148,000 after acquiring an additional 1,074 shares during the period. Finally, Mason Street Advisors LLC grew its holdings in shares of U.S. Physical Therapy by 7.0% in the first quarter. Mason Street Advisors LLC now owns 2,928 shares of the company’s stock worth $191,000 after acquiring an additional 192 shares during the period. 94.95% of the stock is owned by institutional investors.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Analyst Recommendations for U.


<div style=

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

A number of other research analysts have also recently issued reports on the company. BidaskClub upgraded U.S. Physical Therapy from a “strong sell” rating to a “sell” rating in a research note on Thursday, September 28th. Cantor Fitzgerald reiterated a “buy” rating and set a $72.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, September 26th. Sidoti upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $62.00 to $74.00 in a research note on Friday, September 8th. Jefferies Group LLC set a $65.00 price target on U.S. Physical Therapy and gave the stock a “hold” rating in a research note on Friday, August 4th. Finally, Barrington Research upgraded U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $68.00 price target for the company in a research note on Monday, July 3rd. Two analysts have rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company’s stock. U.S. Physical Therapy currently has a consensus rating of “Hold” and an average target price of $68.60.

Shares of U.S. Physical Therapy (NYSE:USPH) opened at 63.50 on Friday. U.S. Physical Therapy has a one year low of $51.96 and a one year high of $78.00. The company has a market cap of $798.89 million, a P/E ratio of 40.19 and a beta of 1.06. The company’s 50-day moving average price is $59.80 and its 200 day moving average price is $62.56.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $0.59 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.60 by ($0.01). The company had revenue of $104.25 million for the quarter, compared to analysts’ expectations of $102.93 million. U.S. Physical Therapy had a net margin of 5.65% and a return on equity of 12.91%. On average, equities research analysts anticipate that U.S. Physical Therapy will post $2.12 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “U.S. Physical Therapy, Inc. (USPH) Rating Lowered to Sell at Zacks Investment Research” was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://ledgergazette.com/2017/10/09/u-s-physical-therapy-inc-usph-rating-lowered-to-sell-at-zacks-investment-research.html.

In related news, CFO Lawrance W. Mcafee sold 3,000 shares of U.S. Physical Therapy stock in a transaction on Friday, August 11th. The stock was sold at an average price of $62.04, for a total value of $186,120.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Glenn Mcdowell sold 2,598 shares of U.S. Physical Therapy stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $57.00, for a total value of $148,086.00. The disclosure for this sale can be found here. Insiders sold 13,266 shares of company stock valued at $801,134 in the last 90 days. Company insiders own 3.10% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the stock. Invictus RG bought a new stake in shares of U.S. Physical Therapy in the first quarter worth $100,000. Pinebridge Investments L.P. grew its holdings in shares of U.S. Physical Therapy by 1.0% in the second quarter. Pinebridge Investments L.P. now owns 1,650 shares of the company’s stock worth $100,000 after acquiring an additional 17 shares during the period. Sei Investments Co. grew its holdings in shares of U.S. Physical Therapy by 9.0% in the first quarter. Sei Investments Co. now owns 1,954 shares of the company’s stock worth $128,000 after acquiring an additional 162 shares during the period. State of Alaska Department of Revenue grew its holdings in shares of U.S. Physical Therapy by 77.8% in the second quarter. State of Alaska Department of Revenue now owns 2,454 shares of the company’s stock worth $148,000 after acquiring an additional 1,074 shares during the period. Finally, Mason Street Advisors LLC grew its holdings in shares of U.S. Physical Therapy by 7.0% in the first quarter. Mason Street Advisors LLC now owns 2,928 shares of the company’s stock worth $191,000 after acquiring an additional 192 shares during the period. 94.95% of the stock is owned by institutional investors.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Analyst Recommendations for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.